ダーマフィラー市場 – 2030年までの世界予測

• 本レポートは、ブランド、製品、施術、エンドユーザー、地域に基づいて、皮膚フィラー市場を調査しています。
• 本レポートでは、市場の成長に影響を与える要因（促進要因、抑制要因、機会、課題など）を分析しています。
• 本レポートでは、利害関係者にとっての市場における機会と課題を評価し、市場リーダーの競争環境の詳細を提供しています。
• 本レポートでは、マイクロ市場の成長傾向、見通し、そして世界の皮膚フィラー市場への貢献について調査しています。
• 本レポートでは、5つの主要地域における市場セグメントの収益予測を行っています。

The derma fillers market is expected to experience significant growth, increasing from USD 4.1 billion in 2025 to USD 7.3 billion by 2030.

ダーマフィラー（皮膚充填剤）市場は、2025 年の 41 億米ドルから 2030 年までに 73 億米ドルに増加すると予想されています。

This growth is fueled by various factors, including demand for minimally invasive aesthetic procedures. Social media trends have normalized and mythologized the use of dermal fillers, particularly among Millennials and Generation Z. Plus, the prevalence of age-related skin issues, such as wrinkles and loss of volume, is stimulating the need for aesthetic treatments.

この成長は、低侵襲美容施術への需要など、様々な要因によって促進されています。ソーシャルメディアのトレンドにより、特にミレニアル世代とZ世代の間で、皮膚充填剤の使用が当たり前のものとなり、神話化されています。さらに、シワやボリューム減少といった加齢に伴う肌トラブルの増加も、美容治療へのニーズを刺激しています。

Fillers are being used for added indications (e.g., jawline, chin, hands) and the demand for customized treatments.

Continuous R&D and improved formulations (e.g., biodegradable and long-lasting injectables) and injection techniques have assured the long-term safety of fillers, making them even more appealing to practitioners and patients. These trends will continue to spur the growth of the global market.

“Natural dermal fillers dominated the market in 2024.”

Natural dermal fillers, particularly those based on hyaluronic acid (HA), collagen, and other biodegradable, biocompatible materials, lead the market because they are highly biocompatible and have little risk of allergic reactions or side effects, all while being reversible as well. The worldwide trend toward less invasive aesthetic procedures for aesthetic improvements is a significant contributor to growth, whereby natural dermal fillers provide a non-surgical alternative for facial rejuvenation, wrinkle correction, and volume restoration. Natural dermal fillers are generation and consumer-driven, sourcing from consumer demand for safety, biocompatibility, and a natural-looking result, as well as consumer trends toward minimally invasive procedures, customizable treatments, and the popularity of social media and youth culture. Hyaluronic acid and other biodegradable fillers dominate natural dermal fillers and highlight consumer priorities, as natural fillers remain the preferred choice in the fast-growing derma fillers market.

“The dermatology clinics & hospitals segment held the largest share of the derma fillers market in 2024.”

Dermatology clinics & hospitals are the primary end user in the derma fillers market, they are being fueled by increasing aesthetic demand with rising consumer interest in facial aesthetics and youthful appearance, product innovation, an expanding treatment indicator where clinics and hospitals are expanding their offerings to facial contouring, volume restoration, lip augmentation, or even hand rejuvenation, based on new product approvals and continuous patient needs. Other influences contributing to the performance, expertise, professional alliances and collaborations, and the socioeconomic environment have allowed procedures to be realized by patients and professionals alike. These drivers collectively provide domain and procedural growth and a lot of uptake in dermal filler procedures in both the clinics and hospital settings.

“The Asia Pacific region is expected to register the highest CAGR in the derma fillers market during the forecast period.”

The Asia Pacific (APAC) region is one of the fastest emerging markets for dermal fillers, with growth driven by an unparalleled combination of demographic, economic, cultural, and technological factors. Demographic changes especially rising awareness and acceptance of aesthetic procedures (in particular among the younger and middle-aged consumer base), economic growth – resulting in a larger middle class with greater spending capacity, which makes non-invasive cosmetic skin treatment options accessible to a much wider audience, R&D and product releases of next-generation fillers which have significantly improved safety, efficacy and longevity, are all contributing factors leading to the growth of the APAC dermal fillers market. The exploding beauty consciousness, social media, continuous economic growth, aging populations, sustained innovation, medical tourism, supportive government policies, and developing healthcare infrastructures represent some of the major accelerators to the APAC dermal fillers market. The APAC derma fillers market is a large and very competitive market undergoing constant and rapid growth, driven by innovation.

A breakdown of the primary participants referred to for this report is provided below:

• By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)

Prominent players in the derma fillers market include Allergan Aesthetics (US), Merz Pharma KGaA (Germany), Galderma (Switzerland), Sinclair Pharma (UK), Bioxis Pharmaceutical (France), Suneva Medical (US), Croma Pharma (Austria), Prollenium Medical Technologies (Canada), Dermax Med (China), Zimmer Aesthetics (Germany), Marllor Biomedical (Italy), MEDYTOX (South Korea), Revance Therapeutic (US), Dr. Korman Pharma (Israel), CGBio Co., Ltd. (South Korea), REGEN Biotech (UK), and BioScience GmbH (Germany), among others.

Research Coverage

• The report studies the derma fillers market based on brand, product, procedure, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets with respect to their growth trends, prospects, and contributions to the global derma fillers market.
• The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying this Report

This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, growth drivers, challenges, and opportunities, supporting strategic decision-making through a balanced analysis.

Through this report, readers get insightful views into the following parameters:

• Analysis of key drivers (Increasing demand for non-invasive aesthetic treatments, continued R&D has grown the sophistication of products, i.e., biodegradable longer-lasting fillers, improved injecting techniques), restraints (Cost barriers to treatment and the need for repeated treatments due to temporary nature of most derma fillers, concerns about adverse effects or complications can also impede market growth), opportunities (Exploration of biodegradable and bioresorbable fillers, potential for fillers to be used in conjunction with other aesthetic treatments, such as the use of botulinum toxin and laser therapy), challenges (the possibility of complications, such as vascular occlusion, granulomas or allergic reactions, can damage patient trust in procedures and also reputation and therefore negatively impact the market), relating to the growth of the derma fillers market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the derma fillers market.
• Market Development: Comprehensive information about lucrative markets – the report analyzes the derma fillers market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the derma fillers market
• Competitive Assessment: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as Allergan Aesthetics (US), Merz Pharma KGaA (Germany), Galderma (Switzerland), Croma Pharma (Austria), Sinclair Pharma (UK), Bioxis Pharmaceutical (France), Suneva Medical (US), Prollenium Medical Technologies (Canada), Dermax Med (China), Zimmer Aesthetics (Germany), Marllor Biomedical (Italy), MEDYTOX (South Korea), Revance Therapeutic (US), Dr. Korman Pharma (Israel), CGBio Co., Ltd. (South Korea), REGEN Biotech (UK), and BioScience GmbH (Germany).

Table of Contents

1               INTRODUCTION              23

1.1           STUDY OBJECTIVES       23

1.2           MARKET DEFINITION   23

1.3           STUDY SCOPE   24

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      24

1.3.2        INCLUSIONS AND EXCLUSIONS 25

1.3.3        YEARS CONSIDERED      25

1.4           CURRENCY CONSIDERED            26

1.5           STAKEHOLDERS               26

2               RESEARCH METHODOLOGY       27

2.1           RESEARCH DATA              27

2.1.1        SECONDARY RESEARCH                28

2.1.1.1    Key secondary sources         28

2.1.1.2    Key data from secondary sources       29

2.1.1.3    Objectives of secondary research       30

2.2           MARKET SIZE ESTIMATION         33

2.2.1        BOTTOM-UP APPROACH              35

2.2.1.1    Approach 1: Company revenue estimation       35

2.2.1.2    Approach 2: Customer-based market estimation             36

2.2.1.3    Approach 3: Primary interviews         37

2.2.2        TOP-DOWN APPROACH                37

2.3           GROWTH FORECAST      38

2.4           DATA TRIANGULATION                41

2.5           RESEARCH ASSUMPTIONS           42

2.6           RESEARCH LIMITATIONS             42

2.7           RISK ANALYSIS  42

3               EXECUTIVE SUMMARY  43

4               PREMIUM INSIGHTS       46

4.1           DERMA FILLERS MARKET OVERVIEW     46

4.2           NORTH AMERICA: DERMA FILLERS MARKET, BY PROCEDURE,

2025 VS. 2030 (USD MILLION)      47

4.3           EUROPE: DERMA FILLERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)                47

4.4           DERMA FILLERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              48

5               MARKET OVERVIEW       49

5.1           INTRODUCTION              49

5.2           MARKET DYNAMICS       49

5.2.1        DRIVERS               50

5.2.1.1    Increasing adoption of minimally invasive and non-invasive aesthetic procedures             50

5.2.1.2    Growing demand for aesthetic treatments among elderly and men                 50

5.2.1.3    Rising acceptance and normalization of fillers among millennials and Gen Z fueled by social media      51

5.2.2        RESTRAINTS      51

5.2.2.1    Risk of infection and safety concerns                 51

5.2.2.2    Complex regulatory framework and compliance standards                 52

5.2.3        OPPORTUNITIES              52

5.2.3.1    Growth opportunities in emerging markets     52

5.2.3.2    Launch of new technologies and products       53

5.2.4        CHALLENGES    53

5.2.4.1    High cost of treatments and devices 53

5.2.4.2    Social and cultural barriers 53

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            54

5.4           PRICING ANALYSIS          54

5.4.1        AVERAGE SELLING PRICE TREND, BY PRODUCT                 55

5.4.2        AVERAGE SELLING PRICE TREND, BY KEY PLAYER                 56

5.4.3        AVERAGE SELLING PRICE TREND, BY REGION   57

5.5           VALUE CHAIN ANALYSIS               59

5.5.1        RESEARCH & DEVELOPMENT    60

5.5.2        RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING          60

5.5.3        DISTRIBUTION, MARKETING & SALES, AND AFTER-SALES SERVICES               60

5.6           SUPPLY CHAIN ANALYSIS             61

5.6.1        PROMINENT COMPANIES            61

5.6.2        SMALL AND MEDIUM-SIZED ENTERPRISES          61

5.6.3        END USERS         61

5.7           ECOSYSTEM ANALYSIS  62

5.8           INVESTMENT AND FUNDING SCENARIO               63

5.9           TECHNOLOGY ANALYSIS             64

5.9.1        KEY TECHNOLOGIES     64

5.9.1.1    Advanced Hyaluronic Acid (HA) cross-linking               64

5.9.1.2    Polymethylmethacrylate (PMMA) fillers         64

5.9.1.3    Bio-stimulatory fillers          64

5.9.2        COMPLEMENTARY TECHNOLOGIES       65

5.9.2.1    Laser resurfacing  65

5.9.2.2    Microneedling       65

5.9.3        ADJACENT TECHNOLOGIES       65

5.9.3.1    3D imaging and AI-based facial mapping         65

5.10         PATENT ANALYSIS          66

5.11         TRADE ANALYSIS             68

5.11.1      IMPORT SCENARIO (HS CODE 330499)    68

5.11.2      EXPORT SCENARIO (HS CODE 330499)    69

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        70

5.13         CASE STUDY ANALYSIS 71

5.13.1      COMMERCIAL PARTNERSHIPS FOR AESTHETIC PRODUCT SALES              71

5.13.2      DIVERSIFICATION OF BUSINESS TO MEET CUSTOMER DEMANDS           71

5.13.3      COLLABORATIONS WITH SMES FOR STREAMLINING LASER-BASED DEVICES 71

5.14         REGULATORY LANDSCAPE         72

5.14.1      REGULATORY ANALYSIS               72

5.14.1.1  North America      72

5.14.1.1.1                US           72

5.14.1.1.2                Canada   72

5.14.1.2  Europe   73

5.14.1.2.1                UK          73

5.14.1.2.2                France    74

5.14.1.2.3                Germany                 74

5.14.1.3  Asia Pacific            74

5.14.1.3.1                Japan      74

5.14.1.3.2                India       75

5.14.1.4  Rest of the World 75

5.14.1.4.1                Brazil      75

5.14.1.4.2                UAE        75

5.14.2      REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  76

5.15         PORTER’S FIVE FORCES ANALYSIS           78

5.15.1      BARGAINING POWER OF SUPPLIERS       79

5.15.2      BARGAINING POWER OF BUYERS             79

5.15.3      THREAT OF NEW ENTRANTS      79

5.15.4      THREAT OF SUBSTITUTES          79

5.15.5      INTENSITY OF COMPETITIVE RIVALRY 79

5.16         KEY STAKEHOLDERS AND BUYING CRITERIA     79

5.16.1      KEY STAKEHOLDERS IN BUYING PROCESS           80

5.16.2      BUYING CRITERIA           81

5.17         REIMBURSEMENT SCENARIO     82

5.18         UNMET NEEDS AND KEY PAIN POINTS  82

5.19         IMPACT OF AI ON DERMA FILLERS MARKET       83

5.19.1      INTRODUCTION              83

5.19.2      MARKET POTENTIAL OF AI ON DERMA FILLERS ECOSYSTEM       83

5.19.3      AI USE CASES     83

5.19.4      KEY COMPANIES IMPLEMENTING AI      84

5.19.5      FUTURE OF GENERATIVE AI IN DERMA FILLERS MARKET               84

5.20         US TARIFF 2025 84

5.20.1      INTRODUCTION              84

5.20.2      KEY TARIFF RATES          85

5.20.3      PRICE IMPACT ANALYSIS             85

5.20.4      IMPACT ON COUNTRY/REGION                86

5.20.4.1  US           86

5.20.4.2  Europe   86

5.20.4.3  Asia Pacific            86

5.20.5      IMPACT ON END-USE INDUSTRIES          86

6               DERMA FILLERS MARKET, BY BRAND     88

6.1           INTRODUCTION              89

6.2           JUVEDERM          89

6.2.1        WIDE INDICATION COVERAGE AND GLOBAL REACH TO CONTRIBUTE TO GROWTH         89

6.3           RESTYLANE        90

6.3.1        FASTER ONSET DURATION AND LONG-LASTING EFFECT TO ENCOURAGE GROWTH         90

6.4           RHA COLLECTION           90

6.4.1        GROWING DESIRE FOR NATURAL EXPRESSIONS TO BOOST MARKET               90

6.5           SCULPTRA           90

6.5.1        INCREASED ADOPTION OF SCULPTRA AMONG ADVANCED INJECTORS TO BOLSTER GROWTH 90

6.6           RADIESSE            91

6.6.1        STABLE SUCCESS RATES AND DESIRED RESULTS TO SPUR GROWTH 91

6.7           LANLUMA            91

6.7.1        EXPANDED USE CASES IN BODY CONTOURING APPLICATIONS TO INTENSIFY GROWTH               91

6.8           BELLAFILL          92

6.8.1        USE OF BELLAFILL FOR TREATING DEEP ACNE SCARS AND NASOLABIAL FOLDS TO FOSTER GROWTH                92

6.9           OTHER BRANDS               92

7               DERMA FILLERS MARKET, BY PRODUCT TYPE   93

7.1           INTRODUCTION              94

7.2           NATURAL DERMAL FILLERS        94

7.2.1        HYALURONIC ACID FILLERS       98

7.2.1.1    Wide clinical acceptance and safety profile to aid growth                 98

7.2.2        COLLAGEN FILLERS       98

7.2.2.1    Ability to provide structural support and improved skin texture to boost market          98

7.3           SYNTHETIC DERMAL FILLERS    99

7.3.1        CALCIUM HYDROXYLAPATITE (CAHA) FILLERS                 103

7.3.1.1    Long-term collagen stimulation property to augment growth                 103

7.3.2        POLY-L-LACTIC ACID (PLLA) FILLERS   103

7.3.2.1    Increasing desire for natural, progressive rejuvenation to stimulate growth   103

7.3.3        POLYMETHYL METHACRYLATE (PMMA) FILLERS                 104

7.3.3.1    Long-lasting structural correction ability to favor growth                 104

7.3.4        POLYNUCLEOTIDE FILLERS       105

7.3.4.1    Rising preference for skin revitalization procedures to fuel market                 105

7.3.5        OTHER SYNTHETIC FILLERS       106

8               DERMA FILLERS MARKET, BY PROCEDURE          107

8.1           INTRODUCTION              108

8.2           SKIN REJUVENATION     108

8.2.1        INCREASING ACCEPTANCE AND REPEATABILITY OF SKIN PROCEDURES TO FACILITATE GROWTH   108

8.3           FACE & BODY CONTOURING      109

8.3.1        RISING NUMBER OF FACIAL AND BODY CONTOURING-RELATED PROCEDURES TO PROMOTE GROWTH             109

8.4           LIP AUGMENTATION     110

8.4.1        NEED FOR REPETITIVE CYCLES TO MAINTAIN DESIRED LOOK TO PROPEL MARKET         110

8.5           OTHER PROCEDURES    111

9               DERMA FILLERS MARKET, BY END USER               112

9.1           INTRODUCTION              113

9.2           DERMATOLOGY CLINICS & HOSPITALS 113

9.2.1        RISING TREND OF MEDICAL TOURISM AND PLASTIC SURGERY TO SUPPORT GROWTH             113

9.3           BEAUTY CENTERS           114

9.3.1        GROWING INCLINATION TOWARD CUSTOMIZED TREATMENT TO DRIVE MARKET              114

9.4           MEDICAL SPAS 115

9.4.1        INCREASING FOCUS ON CONVENIENCE, TREATMENT FLEXIBILITY,

AND COST SAVING TO SPUR GROWTH  115

9.5           OTHER END USERS         116

10            DERMA FILLERS MARKET, BY REGION   117

10.1         INTRODUCTION              118

10.2         NORTH AMERICA             119

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 120

10.2.2      US           122

10.2.2.1  Rising geriatric population to spur growth       122

10.2.3      CANADA               123

10.2.3.1  Preference of aging individuals to reduce aging signs to promote growth    123

10.3         EUROPE               124

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      126

10.3.2      GERMANY           127

10.3.2.1  Large consumer base to expedite growth          127

10.3.3      UK          128

10.3.3.1  Increasing volume-enhancement treatments to support growth                 128

10.3.4      FRANCE                129

10.3.4.1  Favorable demographics and increased acceptance of non-surgical procedures to aid growth      129

10.3.5      ITALY    130

10.3.5.1  Growing acceptance of minimally invasive procedures to fuel market    130

10.3.6      SPAIN    131

10.3.6.1  Increasing availability of safe and minimally invasive treatments to augment growth                131

10.3.7      REST OF EUROPE             132

10.4         ASIA PACIFIC     133

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 134

10.4.2      JAPAN   137

10.4.2.1  Growing trend of volume restoration and wrinkle correction to boost market          137

10.4.3      CHINA  138

10.4.3.1  Surging demand for aesthetic procedures to accelerate growth                 138

10.4.4      INDIA    138

10.4.4.1  Rapid urbanization and proliferation of clinics to stimulate growth    138

10.4.5      AUSTRALIA         139

10.4.5.1  Rising safety standards for non-surgical cosmetic procedures to encourage growth 139

10.4.6      SOUTH KOREA  140

10.4.6.1  Robust medical infrastructure to speed up growth          140

10.4.7      REST OF ASIA PACIFIC   140

10.5         LATIN AMERICA                141

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 143

10.5.2      BRAZIL 144

10.5.2.1  Cultural normalization of aesthetic treatments to contribute to growth    144

10.5.3      MEXICO                145

10.5.3.1  Increasing inflow of medical tourists to sustain growth 145

10.5.4      REST OF LATIN AMERICA             146

10.6         MIDDLE EAST & AFRICA                147

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 147

10.6.2      GCC COUNTRIES              150

10.6.2.1  Booming aesthetic tourism sector to facilitate growth   150

10.6.3      REST OF MIDDLE EAST & AFRICA             151

11            COMPETITIVE LANDSCAPE         152

11.1         INTRODUCTION              152

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            152

11.3         REVENUE ANALYSIS, 2020–2024  154

11.4         MARKET SHARE ANALYSIS, 2024                 155

11.4.1      NATURAL DERMA FILLERS MARKET SHARE         155

11.4.2      SYNTHETIC DERMAL FILLERS MARKET SHARE  155

11.5         COMPANY VALUATION AND FINANCIAL METRICS                 158

11.6         BRAND/PRODUCT COMPARISON             159

11.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 159

11.7.1      STARS   159

11.7.2      EMERGING LEADERS     160

11.7.3      PERVASIVE PLAYERS      160

11.7.4      PARTICIPANTS 160

11.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         161

11.7.5.1  Company footprint               161

11.7.5.2  Region footprint   162

11.7.5.3  Product type footprint         163

11.7.5.4  Procedure footprint              164

11.7.5.5  End-user footprint                165

11.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        165

11.8.1      PROGRESSIVE COMPANIES         165

11.8.2      RESPONSIVE COMPANIES            165

11.8.3      DYNAMIC COMPANIES  166

11.8.4      STARTING BLOCKS         166

11.8.5      COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES              167

11.8.5.1  Detailed list of key startups/SMEs    167

11.8.5.2  Competitive benchmarking of key startups/SMEs          168

11.9         COMPETITIVE SCENARIO             169

11.9.1      PRODUCT LAUNCHES AND APPROVALS               169

11.9.2      DEALS  170

12            COMPANY PROFILES      171

12.1         KEY PLAYERS     171

12.1.1      ABBVIE INC.       171

12.1.1.1  Business overview 171

12.1.1.2  Products offered   172

12.1.1.3  Recent developments           173

12.1.1.3.1                Product launches and approvals         173

12.1.1.4  MnM view              173

12.1.1.4.1                Key strengths        173

12.1.1.4.2                Strategic choices   173

12.1.1.4.3                Weaknesses and competitive threats 174

12.1.2      GALDERMA        175

12.1.2.1  Business overview 175

12.1.2.2  Products offered   176

12.1.2.3  Recent developments           177

12.1.2.3.1                Product launches and approvals         177

12.1.2.3.2                Deals      177

12.1.2.3.3                Expansions             178

12.1.2.4  MnM view              178

12.1.2.4.1                Key strengths        178

12.1.2.4.2                Strategic choices   178

12.1.2.4.3                Weaknesses and competitive threats 178

12.1.3      MERZ PHARMA 179

12.1.3.1  Business overview 179

12.1.3.2  Products offered   180

12.1.3.3  Recent developments           180

12.1.3.3.1                Expansions             181

12.1.3.4  MnM view              182

12.1.3.4.1                Key strengths        182

12.1.3.4.2                Strategic choices   182

12.1.3.4.3                Weaknesses and competitive threats 182

12.1.4      SILCLAIR PHARMA           183

12.1.4.1  Business overview 183

12.1.4.2  Products offered   184

12.1.4.3  MnM view              184

12.1.4.3.1                Key strengths        184

12.1.4.3.2                Strategic choices   184

12.1.4.3.3                Weaknesses and competitive threats 184

12.1.5      REVANCE             185

12.1.5.1  Business overview 185

12.1.5.2  Products offered   185

12.1.5.3  Recent developments           186

12.1.5.3.1                Product launches and approvals         186

12.1.5.3.2                Deals      186

12.1.5.4  MnM view              187

12.1.5.4.1                Key strengths        187

12.1.5.4.2                Strategic choices   187

12.1.5.4.3                Weaknesses and competitive threats 187

12.1.6      CROMA PHARMA              188

12.1.6.1  Business overview 188

12.1.6.2  Products offered   188

12.1.7      EVOLUS, INC.     189

12.1.7.1  Business overview 189

12.1.7.2  Products offered   190

12.1.7.3  Recent developments           190

12.1.7.3.1                Product launches and approvals         190

12.1.8      HUGEL, INC.       191

12.1.8.1  Business overview 191

12.1.8.2  Products offered   192

12.1.9      MEDYTOX           193

12.1.9.1  Business overview 193

12.1.9.2  Products offered   194

12.1.10   BIOXIS PHARMACEUTICAL          195

12.1.10.1                 Business overview 195

12.1.10.2                 Products offered   195

12.1.11   ZIMMER MEDIZINSYSTEME GMBH           196

12.1.11.1                 Business overview 196

12.1.11.2                 Products offered   196

12.1.12   CUTERA, INC.    197

12.1.12.1                 Business overview 197

12.1.12.2                 Products offered   198

12.1.12.3                 Recent developments           198

12.1.12.3.1             Product launches and approvals         198

12.1.12.3.2             Deals      198

12.1.13   SCIVISION BIOTECH INC.             199

12.1.13.1                 Business overview 199

12.1.13.2                 Products offered   200

12.1.14   BRIDGEPOINT GROUP PLC         201

12.1.14.1                 Business overview 201

12.1.14.2                 Products offered   201

12.1.15   ANIKA THERAPEUTICS, INC.       202

12.1.15.1                 Business overview 202

12.1.15.2                 Products offered   203

12.2         OTHER PLAYERS              204

12.2.1      TIGER AESTHETICS MEDICAL    204

12.2.2      PROLLENIUM MEDICAL TECHNOLOGIES             205

12.2.3      BIOSCIENCE GMBH         206

12.2.4      DERMAX               207

12.2.5      TEOXANE            208

12.2.6      DR. KORMAN LABORATORIES LTD.         209

12.2.7      CYTOPHIL, INC.                210

12.2.8      TELETA PHARMA             211

12.2.9      IBSA DERMA       212

12.2.10   NEOGENESIS     213

12.2.11   CGBIO, CO., LTD.             214

13            APPENDIX           215

13.1         DISCUSSION GUIDE        215

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                219

13.3         CUSTOMIZATION OPTIONS        221

13.4         RELATED REPORTS         221

13.5         AUTHOR DETAILS           222

LIST OF TABLES

TABLE 1                DERMA FILLERS MARKET: INCLUSIONS AND EXCLUSIONS      25

TABLE 2                STANDARD CURRENCY CONVERSION RATES, 2021–2023              26

TABLE 3                DERMA FILLERS MARKET: RISK ANALYSIS                 42

TABLE 4                AVERAGE SELLING PRICE TREND OF HYALURONIC ACID FILLERS,

BY KEY PLAYER, 2022–2024 (USD)              56

TABLE 5                AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS,

BY REGION, 2022–2024 (USD)      58

TABLE 6                DERMA FILLERS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 62

TABLE 7                DERMA FILLERS MARKET: INNOVATIONS AND PATENT REGISTRATIONS,

2022–2024              67

TABLE 8                IMPORT DATA FOR HS CODE 330499, BY COUNTRY,

2020–2024 (USD THOUSAND)      68

TABLE 9                EXPORT DATA FOR HS CODE 611510, BY COUNTRY,

2020–2024 (USD THOUSAND)      69

TABLE 10              DERMA FILLERS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026                 70

TABLE 11              US FDA: MEDICAL DEVICE CLASSIFICATION                 72

TABLE 12              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  76

TABLE 13              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  76

TABLE 14              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  77

TABLE 15              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  77

TABLE 16              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  77

TABLE 17              DERMA FILLERS MARKET: PORTER’S FIVE FORCES ANALYSIS           78

TABLE 18              KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING DERMA FILLERS               80

TABLE 19              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DERMA FILLERS,

BY PRODUCT TYPE (%) 81

TABLE 20              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER                81

TABLE 21              REIMBURSEMENT CODES FOR VARIOUS PROCEDURES    82

TABLE 22              UNMET CUSTOMER NEEDS AND KEY PAIN POINTS 82

TABLE 23              US ADJUSTED RECIPROCAL TARIFF RATES                 85

TABLE 24              DERMA FILLERS MARKET, BY BRAND, 2023–2030 (USD MILLION) 89

TABLE 25              DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            94

TABLE 26              NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            94

TABLE 27              NORTH AMERICA: NATURAL DERMAL FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            95

TABLE 28              EUROPE: NATURAL DERMAL FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            95

TABLE 29              ASIA PACIFIC: NATURAL DERMAL FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            96

TABLE 30              LATIN AMERICA: NATURAL DERMAL FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            96

TABLE 31              MIDDLE EAST & AFRICA: NATURAL DERMAL FILLERS MARKET,

BY REGION, 2023–2030 (USD MILLION)   97

TABLE 32              NATURAL DERMAL FILLERS MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)                97

TABLE 33              NATURAL DERMAL FILLERS MARKET, BY END USER, 2023–2030 (USD MILLION)                97

TABLE 34              HYALURONIC ACID FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION)          98

TABLE 35              COLLAGEN FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION)       99

TABLE 36              SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                99

TABLE 37              NORTH AMERICA: SYNTHETIC DERMAL FILLERS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               100

TABLE 38              EUROPE: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            100

TABLE 39              ASIA PACIFIC: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            101

TABLE 40              LATIN AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            101

TABLE 41              MIDDLE EAST & AFRICA: SYNTHETIC DERMAL FILLERS MARKET,

BY REGION, 2023–2030 (USD MILLION)   102

TABLE 42              SYNTHETIC DERMAL FILLERS MARKET, BY PROCEDURE,

2023–2030 (USD MILLION)            102

TABLE 43              SYNTHETIC DERMAL FILLERS MARKET, BY END USER, 2023–2030 (USD MILLION)                102

TABLE 44              CALCIUM HYDROXYLAPATITE (CAHA) FILLERS MARKET,

BY REGION, 2023–2030 (USD MILLION)   103

TABLE 45              POLY-L-LACTIC ACID (PLLA) FILLERS MARKET, BY REGION,

2023–2030 (USD MILLION)            104

TABLE 46              POLYMETHYL METHACRYLATE (PMMA) FILLERS MARKET,

BY REGION, 2023–2030 (USD MILLION)   104

TABLE 47              POLYNUCLEOTIDE FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION)          105

TABLE 48              OTHER SYNTHETIC FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION)          106

TABLE 49              DERMA FILLERS MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)            108

TABLE 50              DERMA FILLERS MARKET FOR SKIN REJUVENATION,

BY REGION, 2023–2030 (USD MILLION)   109

TABLE 51              DERMA FILLERS MARKET FOR FACE & BODY CONTOURING,

BY REGION, 2023–2030 (USD MILLION)   110

TABLE 52              DERMA FILLERS MARKET FOR LIP AUGMENTATION, BY REGION,

2023–2030 (USD MILLION)            110

TABLE 53              DERMA FILLERS MARKET FOR OTHER PROCEDURES, BY REGION,

2023–2030 (USD MILLION)            111

TABLE 54              DERMA FILLERS MARKET, BY END USER, 2023–2030 (USD MILLION)       113

TABLE 55              DERMA FILLERS MARKET FOR DERMATOLOGY CLINICS & HOSPITALS,

BY REGION, 2023–2030 (USD MILLION)   114

TABLE 56              DERMA FILLERS MARKET FOR BEAUTY CENTERS, BY REGION,

2023–2030 (USD MILLION)            115

TABLE 57              DERMA FILLERS MARKET FOR MEDICAL SPAS, BY REGION,

2023–2030 (USD MILLION)            116

TABLE 58              DERMA FILLERS MARKET FOR OTHER END USERS,

BY REGION, 2023–2030 (USD MILLION)   116

TABLE 59              DERMA FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION) 118

TABLE 60              GLOBAL DERMA FILLERS PROCEDURE, 2021–2023        118

TABLE 61              NORTH AMERICA: MACROECONOMIC OUTLOOK           120

TABLE 62              NORTH AMERICA: DERMA FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            120

TABLE 63              NORTH AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            121

TABLE 64              NORTH AMERICA: NATURAL DERMAL FILLERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         121

TABLE 65              NORTH AMERICA: SYNTHETIC DERMAL FILLERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         121

TABLE 66              NORTH AMERICA: DERMA FILLERS MARKET, BY PROCEDURE,

2023–2030 (USD MILLION)            122

TABLE 67              NORTH AMERICA: DERMA FILLERS MARKET, BY END USER,

2023–2030 (USD MILLION)            122

TABLE 68              US: DERMA FILLER PROCEDURES, 2021–2023                 123

TABLE 69              US: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                123

TABLE 70              CANADA: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            124

TABLE 71              EUROPE: DERMA FILLERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     124

TABLE 72              EUROPE: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            125

TABLE 73              EUROPE: NATURAL DERMAL FILLERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            125

TABLE 74              EUROPE: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            125

TABLE 75              EUROPE: DERMA FILLERS MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)                126

TABLE 76              EUROPE: DERMA FILLERS MARKET, BY END USER, 2023–2030 (USD MILLION)                126

TABLE 77              EUROPE: MACROECONOMIC OUTLOOK                 127

TABLE 78              GERMANY: DERMA FILLER PROCEDURES, 2021–2023        127

TABLE 79              GERMANY: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            128

TABLE 80              UK: DERMA FILLER PROCEDURES, 2022–2023                 128

TABLE 81              UK: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                128

TABLE 82              FRANCE: DERMA FILLER PROCEDURES, 2023                 129

TABLE 83              FRANCE: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            129

TABLE 84              ITALY: DERMA FILLER PROCEDURES, 2021–2023                 130

TABLE 85              ITALY: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                130

TABLE 86              SPAIN: DERMA FILLER PROCEDURES, 2021–2023                 131

TABLE 87              SPAIN: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                131

TABLE 88              REST OF EUROPE: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            132

TABLE 89              ASIA PACIFIC: MACROECONOMIC OUTLOOK                 134

TABLE 90              ASIA PACIFIC: DERMA FILLERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     135

TABLE 91              ASIA PACIFIC: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            135

TABLE 92              ASIA PACIFIC: NATURAL DERMAL FILLERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            135

TABLE 93              ASIA PACIFIC: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            136

TABLE 94              ASIA PACIFIC: DERMA FILLERS MARKET, BY PROCEDURE,

2023–2030 (USD MILLION)            136

TABLE 95              ASIA PACIFIC: DERMA FILLERS MARKET, BY END USER,

2023–2030 (USD MILLION)            137

TABLE 96              JAPAN: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                137

TABLE 97              CHINA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                138

TABLE 98              INDIA: DERMA FILLER PROCEDURES, 2021–2023                 139

TABLE 99              INDIA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                139

TABLE 100            AUSTRALIA: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            139

TABLE 101            SOUTH KOREA: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            140

TABLE 102            REST OF ASIA PACIFIC: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            141

TABLE 103            LATIN AMERICA: DERMA FILLERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            141

TABLE 104            LATIN AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            142

TABLE 105            LATIN AMERICA: NATURAL DERMAL FILLERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         142

TABLE 106            LATIN AMERICA: SYNTHETIC DERMAL FILLERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         142

TABLE 107            LATIN AMERICA: DERMA FILLERS MARKET, BY PROCEDURE,

2023–2030 (USD MILLION)            143

TABLE 108            LATIN AMERICA: DERMA FILLERS MARKET, BY END USER,

2023–2030 (USD MILLION)            143

TABLE 109            LATIN AMERICA: MACROECONOMIC OUTLOOK                 144

TABLE 110            BRAZIL: DERMA FILLER PROCEDURES, 2021–2023        144

TABLE 111            BRAZIL: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)         145

TABLE 112            MEXICO: DERMA FILLER PROCEDURES, 2021–2023        145

TABLE 113            MEXICO: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            146

TABLE 114            REST OF LATIN AMERICA: DERMA FILLERS MARKET,

BY PRODUCT TYPE, 2023–2030 (USD MILLION)  146

TABLE 115            MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK           148

TABLE 116            MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY REGION,

2023–2030 (USD MILLION)            148

TABLE 117            MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            148

TABLE 118            MIDDLE EAST & AFRICA: NATURAL DERMAL FILLERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         149

TABLE 119            MIDDLE EAST & AFRICA: SYNTHETIC DERMAL FILLERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         149

TABLE 120            MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PROCEDURE,

2023–2030 (USD MILLION)            150

TABLE 121            MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY END USER,

2023–2030 (USD MILLION)            150

TABLE 122            GCC COUNTRIES: DERMA FILLERS MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            151

TABLE 123            REST OF MIDDLE EAST & AFRICA: DERMA FILLERS MARKET,

BY PRODUCT TYPE, 2023–2030 (USD MILLION)  151

TABLE 124            OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN DERMA FILLERS MARKET, JANUARY 2022–MAY 2025        152

TABLE 125            DERMA FILLERS MARKET: DEGREE OF COMPETITION 156

TABLE 126            DERMA FILLERS MARKET: REGION FOOTPRINT                 162

TABLE 127            DERMA FILLERS MARKET: PRODUCT TYPE FOOTPRINT       163

TABLE 128            DERMA FILLERS MARKET: PROCEDURE FOOTPRINT       164

TABLE 129            DERMA FILLERS MARKET: END-USER FOOTPRINT       165

TABLE 130            DERMA FILLERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES    167

TABLE 131            DERMA FILLERS MARKET: COMPETITIVE BENCHMARKING OF

KEY STARTUPS/SMES    168

TABLE 132            DERMA FILLERS MARKET: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–MAY 2025               169

TABLE 133            DERMA FILLERS MARKET: DEALS, JANUARY 2021–MAY 2025   170

TABLE 134            ABBVIE INC.: COMPANY OVERVIEW        171

TABLE 135            ABBVIE INC.: PRODUCTS OFFERED         172

TABLE 136            ABBVIE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025    173

TABLE 137            GALDERMA: COMPANY OVERVIEW         175

TABLE 138            GALDERMA: PRODUCTS OFFERED          176

TABLE 139            GALDERMA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025    177

TABLE 140            GALDERMA: DEALS, JANUARY 2021–MAY 2025                 177

TABLE 141            GALDERMA: EXPANSIONS, JANUARY 2021–MAY 2025        178

TABLE 142            MERZ PHARMA: COMPANY OVERVIEW  179

TABLE 143            MERZ PHARMA: PRODUCTS OFFERED   180

TABLE 144            MERZ PHARMA: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–MAY 2025               180

TABLE 145            MERZ PHARMA: EXPANSIONS, JANUARY 2021–MAY 2024              181

TABLE 146            SILCLAIR PHARMA: COMPANY OVERVIEW                 183

TABLE 147            SILCLAIR PHARMA: PRODUCTS OFFERED                 184

TABLE 148            REVANCE: COMPANY OVERVIEW              185

TABLE 149            REVANCE: PRODUCTS OFFERED               185

TABLE 150            REVANCE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025    186

TABLE 151            REVANCE: DEALS, JANUARY 2021–MAY 2025                 186

TABLE 152            CROMA PHARMA: COMPANY OVERVIEW                 188

TABLE 153            CROMA PHARMA: PRODUCTS OFFERED                 188

TABLE 154            EVOLUS, INC.: COMPANY OVERVIEW     189

TABLE 155            EVOLUS, INC.: PRODUCTS OFFERED      190

TABLE 156            EVOLUS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025    190

TABLE 157            HUGEL, INC.: COMPANY OVERVIEW       191

TABLE 158            HUGEL, INC.: PRODUCTS OFFERED        192

TABLE 159            MEDYTOX: COMPANY OVERVIEW            193

TABLE 160            MEDYTOX: PRODUCTS OFFERED             194

TABLE 161            BIOXIS PHARMACEUTICAL: COMPANY OVERVIEW          195

TABLE 162            BIOXIS PHARMACEUTICAL: PRODUCTS OFFERED             195

TABLE 163            ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW          196

TABLE 164            ZIMMER MEDIZINSYSTEME GMBH: PRODUCTS OFFERED             196

TABLE 165            CUTERA, INC.: COMPANY OVERVIEW     197

TABLE 166            CUTERA, INC.: PRODUCTS OFFERED      198

TABLE 167            CUTERA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025    198

TABLE 168            CUTERA, INC.: DEALS, JANUARY 2021–MAY 2025                 198

TABLE 169            SCIVISION BIOTECH INC.: COMPANY OVERVIEW          199

TABLE 170            SCIVISION BIOTECH INC.: PRODUCTS OFFERED                 200

TABLE 171            BRIDGEPOINT GROUP PLC: COMPANY OVERVIEW          201

TABLE 172            BRIDGEPOINT GROUP PLC: PRODUCTS OFFERED             201

TABLE 173            ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW          202

TABLE 174            ANIKA THERAPEUTICS, INC.: PRODUCTS OFFERED             203

TABLE 175            TIGER AESTHETICS MEDICAL: COMPANY OVERVIEW          204

TABLE 176            PROLLENIUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW   205

TABLE 177            BIOSCIENCE GMBH: COMPANY OVERVIEW                 206

TABLE 178            DERMAX: COMPANY OVERVIEW               207

TABLE 179            TEOXANE: COMPANY OVERVIEW             208

TABLE 180            DR. KORMAN LABORATORIES LTD.: COMPANY OVERVIEW          209

TABLE 181            CYTOPHIL, INC.: COMPANY OVERVIEW 210

TABLE 182            TELETA PHARMA: COMPANY OVERVIEW                 211

TABLE 183            IBSA DERMA: COMPANY OVERVIEW       212

TABLE 184            NEOGENESIS: COMPANY OVERVIEW      213

TABLE 185            CGBIO, CO., LTD.: COMPANY OVERVIEW                 214

LIST OF FIGURES

FIGURE 1              DERMA FILLERS MARKET SEGMENTATION AND REGIONAL SCOPE            24

FIGURE 2              DERMA FILLERS MARKET: RESEARCH DESIGN                 27

FIGURE 3              DERMA FILLERS MARKET: RESEARCH DATA                 29

FIGURE 4              KEY PRIMARY SOURCES                31

FIGURE 5              SUPPLY- AND DEMAND-SIDE PARTICIPANTS                 31

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     32

FIGURE 7              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           34

FIGURE 8              MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 35

FIGURE 9              DERMA FILLERS MARKET SIZE ESTIMATION METHODOLOGY              36

FIGURE 10            MARKET SIZE ESTIMATION: TOP-DOWN APPROACH         37

FIGURE 11            GROWTH RATE PROJECTIONS BASED ON MARKET DRIVERS            39

FIGURE 12            GROWTH RATE PROJECTIONS BASED ON MARKET OPPORTUNITIES,

RESTRAINTS, AND CHALLENGES              40

FIGURE 13            DATA TRIANGULATION                41

FIGURE 14            DERMA FILLERS MARKET, BY BRAND, 2025 VS. 2030        43

FIGURE 15            DERMA FILLERS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)      44

FIGURE 16           DERMA FILLERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)       44

FIGURE 17            DERMA FILLERS MARKET: GEOGRAPHIC SNAPSHOT (2024)             45

FIGURE 18            INCREASED AESTHETIC CONSCIOUSNESS AND RISING DISPOSABLE INCOME

TO DRIVE MARKET         46

FIGURE 19            SKIN REJUVENATION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD    47

FIGURE 20            DERMATOLOGY CLINICS & HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD                 47

FIGURE 21            CHINA TO REGISTER HIGHEST CAGR FROM 2025 TO 2030                 48

FIGURE 22            DERMA FILLERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          49

FIGURE 23            NEW REVENUE POCKETS FOR PLAYERS IN DERMA FILLERS MARKET             54

FIGURE 24            AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS,

BY TYPE, 2022–2024 (USD)            55

FIGURE 25            AVERAGE SELLING PRICE TREND OF HYALURONIC ACID FILLERS,

BY KEY PLAYER, 2022–2024 (USD)              56

FIGURE 26            AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS,

BY REGION, 2022–2024 (USD)      57

FIGURE 27            DERMA FILLERS MARKET: VALUE CHAIN ANALYSIS            59

FIGURE 28            DERMA FILLERS MARKET: SUPPLY CHAIN ANALYSIS            61

FIGURE 29            DERMA FILLERS MARKET: ECOSYSTEM ANALYSIS            62

FIGURE 30            INVESTMENT AND FUNDING SCENARIO, 2019–2023 (USD MILLION)       63

FIGURE 31            NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023              63

FIGURE 32            VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)            64

FIGURE 33            DERMA FILLERS MARKET: PATENT ANALYSIS, 2014–2024              66

FIGURE 34            DERMA FILLERS MARKET: IMPORT SCENARIO FOR HS CODE 330499,

BY COUNTRY, 2020–2024 (USD THOUSAND)         68

FIGURE 35            DERMA FILLERS MARKET: EXPORT SCENARIO FOR HS CODE 330499,

BY COUNTRY, 2020–2024 (USD THOUSAND)         69

FIGURE 36            DERMA FILLERS MARKET: PORTER’S FIVE FORCES ANALYSIS           78

FIGURE 37            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DERMA FILLERS,

BY PRODUCT TYPE         80

FIGURE 38            KEY BUYING CRITERIA FOR TOP THREE END USERS   81

FIGURE 39            NORTH AMERICA: DERMA FILLERS MARKET SNAPSHOT          119

FIGURE 40            ASIA PACIFIC: DERMA FILLERS MARKET SNAPSHOT          133

FIGURE 41            REVENUE ANALYSIS OF KEY PLAYERS IN DERMA FILLERS MARKET, 2020–2024        154

FIGURE 42            NATURAL DERMAL FILLERS MARKET SHARE ANALYSIS, 2024  155

FIGURE 43            SYNTHETIC DERMA FILLERS MARKET SHARE ANALYSIS, 2024  155

FIGURE 44            EV/EBITDA OF KEY VENDORS   158

FIGURE 45            5-YEAR STOCK BETA OF KEY VENDORS 158

FIGURE 46            DERMA FILLERS MARKET: BRAND/PRODUCT COMPARISON   159

FIGURE 47            DERMA FILLERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         160

FIGURE 48            DERMA FILLERS MARKET: COMPANY FOOTPRINT       161

FIGURE 49            DERMA FILLERS MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2024                166

FIGURE 50            ABBVIE INC.: COMPANY SNAPSHOT (2024)                 172

FIGURE 51            GALDERMA: COMPANY SNAPSHOT (2024)                 176

FIGURE 52            EVOLUS, INC.: COMPANY SNAPSHOT (2024)                 190

FIGURE 53            HUGEL, INC.: COMPANY SNAPSHOT (2024)                 192

FIGURE 54            MEDYTOX: COMPANY SNAPSHOT (2024)                 194

FIGURE 55            SCIVISION BIOTECH INC.: COMPANY SNAPSHOT (2024)             200

FIGURE 56            ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2024)             203

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧